66 related articles for article (PubMed ID: 3796554)
21. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
Gerö L; Korányi L; Tamás G
Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
[TBL] [Abstract][Full Text] [Related]
22. Urinary C-peptide: a useful tool for evaluating the endogenous insulin reserve in cohort and longitudinal studies of diabetes in childhood.
de Beaufort CE; den Boer NC; Bruining GJ; Eilers GA; van Strik R; Weterings T
Ann Clin Biochem; 1988 Sep; 25 ( Pt 5)():552-9. PubMed ID: 3069047
[TBL] [Abstract][Full Text] [Related]
23. [Insulin and C-peptide in the blood serum of children and adolescents with diabetes mellitus].
Balabolkin MI; Zubovskiĭ GA; Stuliĭ LA; Domanova VT
Med Radiol (Mosk); 1980 Jun; 25(6):34-7. PubMed ID: 6993830
[No Abstract] [Full Text] [Related]
24. Plasma C-peptide in long-standing type 1 diabetics with and without microvascular disease.
Bodansky HJ; Medbak S; Drury PL; Cudworth AG
Diabete Metab; 1981 Dec; 7(4):265-9. PubMed ID: 7333406
[TBL] [Abstract][Full Text] [Related]
25. GADA and islet cell antibodies in Romanian children and adolescents with diabetes mellitus.
Serban V; Enache A; Vlad A; Sima A; Roşu M; Roşca A; Drăghici C
Rom J Intern Med; 2004; 42(2):325-32. PubMed ID: 15529623
[TBL] [Abstract][Full Text] [Related]
26. [C-peptide in type I diabetics].
Perusicová J; Skachová J
Vnitr Lek; 1986 Jun; 32(6):581-6. PubMed ID: 3739249
[No Abstract] [Full Text] [Related]
27. Twenty-four hour urinary C-peptide and fasting plasma C-peptide as indicators of metabolic control in 83 insulin dependent diabetic patients.
Yoo HJ; Hartling SG; Binder C
Korean J Intern Med; 1987 Jul; 2(2):196-200. PubMed ID: 3154831
[TBL] [Abstract][Full Text] [Related]
28. Urine C-peptide, beta-cell function, and insulin requirement.
Rappaport EB; Ulstrom RA; Etzwiler DD; Fife D; Hedlund BE; Steffes MW
Am J Dis Child; 1980 Dec; 134(12):1129-33. PubMed ID: 7004175
[TBL] [Abstract][Full Text] [Related]
29. Methodological aspects on C-peptide measurements.
Ludvigsson J
Acta Med Scand Suppl; 1983; 671():53-9. PubMed ID: 6576623
[TBL] [Abstract][Full Text] [Related]
30. The message for MODY.
Hitman GA
Diabet Med; 2011 Sep; 28(9):1009. PubMed ID: 21843300
[No Abstract] [Full Text] [Related]
31. [Urinalysis of school children for the screening of juvenile diabetes mellitus (for 3 consecutive years in a single area) and C-peptide secretory capacity during 50g glucose loading].
Mano T; Fujita H
Horumon To Rinsho; 1977 Sep; 25(9):964-73. PubMed ID: 923121
[No Abstract] [Full Text] [Related]
32. [Application of artificial endocrine pancreas. - Improvement in insulin secretory ability and normalization of metabolic and endocrine disorders in diabetic subjects].
Kawamori R; Shichiri M
Horumon To Rinsho; 1982 Jul; 30(7):667-70. PubMed ID: 7127862
[No Abstract] [Full Text] [Related]
33. C-peptide an adequate endpoint in type 1 diabetes.
Ludvigsson J
Diabetes Metab Res Rev; 2009 Nov; 25(8):691-3. PubMed ID: 19877135
[No Abstract] [Full Text] [Related]
34. Higher post-absorptive C-peptide levels in Type 1 diabetic patients without renal complications.
Zerbini G; Mangili R; Luzi L
Diabet Med; 1999 Dec; 16(12):1048. PubMed ID: 10656236
[No Abstract] [Full Text] [Related]
35. Urine C-peptide creatinine ratio is a noninvasive alternative to the mixed-meal tolerance test in children and adults with type 1 diabetes.
Besser RE; Ludvigsson J; Jones AG; McDonald TJ; Shields BM; Knight BA; Hattersley AT
Diabetes Care; 2011 Mar; 34(3):607-9. PubMed ID: 21285386
[TBL] [Abstract][Full Text] [Related]
36. C-Peptide and 24-Hour Urinary C-Peptide as Markers to Help Classify Types of Childhood Diabetes.
Levitt Katz LE
Horm Res Paediatr; 2015; 84(1):62-4. PubMed ID: 26045021
[No Abstract] [Full Text] [Related]
37. C-peptide: should we be testing this routinely in the Type 1 diabetes clinic?
Huda MS; Hitman GA
Diabet Med; 2015 Oct; 32(10):1259-60. PubMed ID: 26387579
[No Abstract] [Full Text] [Related]
38. [C-peptide (CPR)].
Matsuda K; Oka Y
Nihon Rinsho; 1999 Dec; 57 Suppl():313-6. PubMed ID: 10778126
[No Abstract] [Full Text] [Related]
39. Clinical significance of C-peptide.
Rubenstein AH; Gonen B
Adv Exp Med Biol; 1979; 124():15-28. PubMed ID: 506831
[No Abstract] [Full Text] [Related]
40. CD3-antibody therapy in new-onset type 1 diabetes mellitus.
Haller MJ; Schatz DA
N Engl J Med; 2005 Nov; 353(19):2086-7; author reply 2086-7. PubMed ID: 16282188
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
